Dr. Adrienne Duff:

It goes back to what we said in our opening statement. We accept there was a lapse in our procedures in terms of the depth of follow-up and the timeliness of our follow-up. Following our engagements with the scoping inquiry, we carried out an on-site assessment of MedLab Pathology, which included the Dublin and Manchester sites.